Nakagomi, T.
Do, L. P.
Agbemabiese, C. A.
Kaneko, M.
Gauchan, P.
Doan, Y. H.
Jere, K. C.
Steele, A. D.
Iturriza-Gomara, M.
Nakagomi, O.
Cunliffe, N. A.
Funding for this research was provided by:
Japan Society for the Promotion of Science (22406014)
Article History
Received: 16 August 2016
Accepted: 30 September 2016
First Online: 7 October 2016
Compliance with ethical standards
:
: This study was supported by a Grant-in-aid for overseas scientific research from Japan Society for the Promotion of Science awarded to Toyoko Nakagomi (No. 22406014). This study was also supported by the Global Centre of Excellence Program on Integrated Global Control Strategy for Tropical and Emerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, Japan.
: The authors declare that they have no conflict of interest regarding this study.
: This study was performed in accordance with the ethical standards of the review boards of all relevant institutions. Informed consent was obtained from the parents/guardians of all individual participants included in the original study. The use of specimens for this study was also approved by both PATH and GlaxoSmithKline Biologicals.